Sign in

CIK 0001642380 · Non-accelerated filer<br>Smaller reporting company

Insight Molecular Diagnostics Inc.

Sign in to watch
Ticker
IMDX
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
CA
Entity type
operating
EIN
271041563
Phone
949-409-7600
Business address
2 INTERNATIONAL PLAZA DR., SUITE 510, NASHVILLE, TN, 37217
Former names
OncoCyte Corp, Oncocyte Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-12-05 James Andrea S. Chief Financial Officer Purchase +20,000 $2.29 $46K 53,670
2024-10-11 James Andrea S. Chief Financial Officer Grant or award · Options to Purchase Common Stock +200,000 200,000
2024-10-11 James Andrea S. Chief Financial Officer Grant or award · Restricted Stock Units +100,000 100,000
2024-10-02 James Andrea S. Chief Financial Officer Purchase +33,670 $2.97 $100K 33,670
2024-10-02 BROADWOOD PARTNERS, L.P. 10% owner Purchase +1,315,339 $2.95 $3.9M 6,244,405
2024-10-02 BROADWOOD PARTNERS, L.P. 10% owner Purchase +0 6,244,405
2024-07-01 Arno Andrew Director Grant or award · Option to Purchase Common Stock +30,000 30,000
2024-07-01 Last Andrew J. Director Grant or award · Option to Purchase Common Stock +30,000 30,000
2024-07-01 SILVERMAN LOU Director Grant or award · Option to Purchase Common Stock +30,000 30,000
2024-06-20 James Andrea S. Chief Financial Officer Grant or award · Option to Purchase Common Stock +200,000 200,000
2024-06-20 James Andrea S. Chief Financial Officer Grant or award · Restricted Stock Units +100,000 300,000
2024-05-20 Liu James Yang Sr Dir., Cntlr, PAO, Int PFO Grant or award · Option to Purchase Common Stock +10,000 10,000
2024-05-20 Arno Andrew Director Grant or award · Option to Purchase Common Stock +20,000 20,000
2024-05-20 Riggs Josh CEO and President Grant or award · Option to Purchase Common Stock +90,000 90,000
2024-04-15 BROADWOOD PARTNERS, L.P. 10% owner Other disposition · Series A Convertible Preferred Stock −2,941.18 0
2024-04-15 BROADWOOD PARTNERS, L.P. 10% owner Other disposition · Series A Convertible Preferred Stock −0 0
2024-04-11 Riggs Josh CEO and President Purchase +3,390 $2.95 $10K 3,505
2024-04-11 Arno Andrew Director Purchase +33,898 $2.95 $100K 69,054
2024-04-11 BROADWOOD PARTNERS, L.P. 10% owner Purchase +2,420,000 $2.92 $7.1M 4,929,066
2024-04-11 BROADWOOD PARTNERS, L.P. 10% owner Purchase +0 4,929,066

Page 4 of 12 · 222 trades